Results 131 to 140 of about 41,733 (183)

Crosstalk between KRAS and miRNAs in pancreatic cancer: Opportunities for its diagnosis, prognosis and therapeutic intervention (Review). [PDF]

Int J Oncol
Aloliqi AA, Alnuqaydan AM, Alshebremi M, Rahmani AH, Khan AA.   +4 more
europepmc   +1 more source

Prolonged response to pembrolizumab in BRAFV600E microsatellite stable metastatic colorectal cancer following an increase in tumor mutational burden. [PDF]

Oncologist
Yang YH, Starling N, Cartwright E.
europepmc   +1 more source

Encorafenib plus binimetinib versus dabrafenib plus trametinib for the first-line treatment of patients with BRAF^V600E-mutant metastatic non-small cell lung cancer: a matching-adjusted indirect treatment comparison. [PDF]

ESMO Open
Planchard D, Mazières J, Grouin JM, Le Reun C, Luttenauer H, Boussahoua M, Macabeo B.   +6 more
europepmc   +1 more source

Precision Medicine in Treating Lung Cancer: A Narrative Review on Treatments Targeting Oncogenic Genetic Mutations. [PDF]

Cureus
Chitneni E, Venugopal A, Okorie CO, George AT, Arya A, Arias D, Yasin O, Cereser Prado de Souza L, Afshan R, Dave VA.   +9 more
europepmc   +1 more source

A Case of Immunotherapy Response to BRAF^V600E-Mutant Lung Adenocarcinoma With Initial Resistance to Dabrafenib and Trametinib Combination Therapy. [PDF]

Cancer Rep (Hoboken)
Okayama Y, Tokito T, Shiraishi S, Takaki R, Tsuneyoshi S, Yamada H, Nishiyama M, Sueyasu Y, Hoshino T.   +8 more
europepmc   +1 more source

Computational-experimental repurposing reveals synergistic sorafenib/hydroxychloroquine response in KRAS-mutant breast cancer. [PDF]

BMC Pharmacol Toxicol
Abdelwahab MM, Soliman M, Nassrallah A.
europepmc   +1 more source

<i>Ferula gummosa</i> in colorectal cancer: a bioinformatics and experimental validation study. [PDF]

Res Pharm Sci
Alibakhshi A, Gharibi S, Shojaeian A, Asgari A, Amini R, Rahimmalek M, Ahangarzadeh S, Szumny A.   +7 more
europepmc   +1 more source

NF1 and SPRED1/2 cooperate through RAS-MAPK-independent functions. [PDF]

Proc Natl Acad Sci U S A
Silva JM, Canche L, Cheng A, Young LC, McCormick F.   +4 more
europepmc   +1 more source

The Potential of Phytochemicals to Overcome Multidrug Resistance in Metastatic Melanoma. [PDF]

Chem Biodivers
Maphutha J, Twilley D, Dawood M, Efferth T, Efferth T, Lall N.   +5 more
europepmc   +1 more source

Diagnostic Challenges in Sessile Serrated Lesions: Progression to Adenocarcinoma in a High-Risk Patient. [PDF]

Am J Case Rep
Ahmed S, Kaur H, Diab MO, Nadir A.
europepmc   +1 more source